Orgenesis signs deal with Accellix, invites Academy Award winner on Scientific board - Vered Caplan, CEO, Orgenesis Inc 00:00:00

Share On Facebook Share On Twitter

Orgenesis (NASDAQ: ORGS) President and CEO Vered Caplan joined Steve Darling from our Proactive New York studio to discuss the company signing an important co-development deal with Accellix. That company specializes in assay migration and delivery platforms for on-demand process analytics.

Recent Videos